Clinical Trials Directory

Trials / Sponsors / Longeveron Inc.

Longeveron Inc.

Industry · 10 registered clinical trials.

StatusTrialPhaseStarted
WithdrawnSafety and Efficacy Trial Using Allogeneic Human Mesenchymal Stem Cells: The SIRONA Trial
Metabolic Disease, Endothelial Dysfunction
Phase 22023-12-01
CompletedLomecel-B Effects on Alzheimer's Disease
Mild Alzheimer's Disease
Phase 22021-12-28
Active Not RecruitingEvaluation of Lomecel-B™ Injection in Patients With Hypoplastic Left Heart Syndrome (HLHS): A Phase IIb Clinic
Hypoplastic Left Heart Syndrome
Phase 22021-06-25
UnknownRegenerative Medicine for COVID-19 and Flu-Elicited ARDS Using Lomecel-B (RECOVER)
ARDS, Human, Covid19
Phase 12020-07-24
UnknownLomecel-B Delivered During Stage II Surgery for Hypoplastic Left Heart Syndrome (ELPIS)
HLHS
Phase 1 / Phase 22018-02-21
CompletedPhase IIb Trial to Evaluate Longeveron Mesenchymal Stem Cells to Treat Aging Frailty
Aging Frailty
Phase 22017-07-06
CompletedLomecel-B on Vaccine-Specific Antibody- Response in Subjects With Aging Frailty
Aging Frailty
Phase 1 / Phase 22016-11-01
CompletedLomecel-B Infusion Versus Placebo in Patients With Alzheimer's Disease
Alzheimer's Disease
Phase 12016-10-10
TerminatedAllogeneic hMSC Injection in Patients With Hypoplastic Left Heart Syndrome
Hypoplastic Left Heart Syndrome
Phase 12015-04-01
CompletedAllogeneiC Human Mesenchymal Stem Cells (hMSC) in Patients With Aging FRAilTy Via IntravenoUS Delivery
Frailty
Phase 1 / Phase 22014-03-03